Addison Davis Diagnostics (932127) SEC Filing 8-K Material Event for the period ending Wednesday, October 19, 2005

Addison Davis Diagnostics

CIK: 932127

View differences made from one to another to evaluate Addison Davis Diagnostics's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Addison Davis Diagnostics.


Assess how Addison Davis Diagnostics's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Addison Davis Diagnostics's Definitive Proxy Statement (Form DEF 14A) filed after their 2005 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
CIK: 932127
Form Type: 8-K Corporate News
Accession Number: 0001144204-05-032254
Submitted to the SEC: Thu Oct 20 2005 6:22:10 PM EST
Accepted by the SEC: Fri Oct 21 2005
Period: Wednesday, October 19, 2005
Industry: Pharmaceutical Preparations
  1. Other Events

External Resources:

Bookmark the Permalink: